• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童多系统炎症综合征相关的神经和心理后遗症。

Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children.

机构信息

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.

Department of Neurology, Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA Netw Open. 2023 Jul 3;6(7):e2324369. doi: 10.1001/jamanetworkopen.2023.24369.

DOI:10.1001/jamanetworkopen.2023.24369
PMID:37466939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10357334/
Abstract

IMPORTANCE

Acute neurological involvement occurs in some patients with multisystem inflammatory syndrome in children (MIS-C), but few data report neurological and psychological sequelae, and no investigations include direct assessments of cognitive function 6 to 12 months after discharge.

OBJECTIVE

To characterize neurological, psychological, and quality of life sequelae after MIS-C.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional cohort study was conducted in the US and Canada. Participants included children with MIS-C diagnosed from November 2020 through November 2021, 6 to 12 months after hospital discharge, and their sibling or community controls, when available. Data analysis was performed from August 2022 to May 2023.

EXPOSURE

Diagnosis of MIS-C.

MAIN OUTCOMES AND MEASURES

A central study site remotely administered a onetime neurological examination and in-depth neuropsychological assessment including measures of cognition, behavior, quality of life, and daily function. Generalized estimating equations, accounting for matching, assessed for group differences.

RESULTS

Sixty-four patients with MIS-C (mean [SD] age, 11.5 [3.9] years; 20 girls [31%]) and 44 control participants (mean [SD] age, 12.6 [3.7] years; 20 girls [45%]) were enrolled. The MIS-C group exhibited abnormalities on neurological examination more frequently than controls (15 of 61 children [25%] vs 3 of 43 children [7%]; odds ratio, 4.7; 95% CI, 1.3-16.7). Although the 2 groups performed similarly on most cognitive measures, the MIS-C group scored lower on the National Institutes of Health Cognition Toolbox List Sort Working Memory Test, a measure of executive functioning (mean [SD] scores, 96.1 [14.3] vs 103.1 [10.5]). Parents reported worse psychological outcomes in cases compared with controls, particularly higher scores for depression symptoms (mean [SD] scores, 52.6 [13.1] vs 47.8 [9.4]) and somatization (mean [SD] scores, 55.5 [15.5] vs 47.0 [7.6]). Self-reported (mean [SD] scores, 79.6 [13.1] vs 85.5 [12.3]) and parent-reported (mean [SD] scores, 80.3 [15.5] vs 88.6 [13.0]) quality of life scores were also lower in cases than controls.

CONCLUSIONS AND RELEVANCE

In this cohort study, compared with contemporaneous sibling or community controls, patients with MIS-C had more abnormal neurologic examinations, worse working memory scores, more somatization and depression symptoms, and lower quality of life 6 to 12 months after hospital discharge. Although these findings need to be confirmed in larger studies, enhanced monitoring may be warranted for early identification and treatment of neurological and psychological symptoms.

摘要

重要性

急性神经系统受累发生在一些儿童多系统炎症综合征(MIS-C)患者中,但很少有数据报告神经系统和心理后遗症,也没有研究包括出院后 6 至 12 个月对认知功能的直接评估。

目的

描述 MIS-C 后的神经、心理和生活质量后遗症。

设计、地点和参与者:这是一项在美国和加拿大进行的横断面队列研究。参与者包括 2020 年 11 月至 2021 年 11 月期间诊断为 MIS-C 的儿童,出院后 6 至 12 个月,并在可能的情况下纳入其兄弟姐妹或社区对照者。数据分析于 2022 年 8 月至 2023 年 5 月进行。

暴露

MIS-C 的诊断。

主要结局和测量

一个中心研究站点远程进行了一次性神经检查和深入的神经心理学评估,包括认知、行为、生活质量和日常功能的测量。广义估计方程,考虑匹配,评估组间差异。

结果

64 名 MIS-C 患儿(平均[SD]年龄,11.5[3.9]岁;20 名女孩[31%])和 44 名对照参与者(平均[SD]年龄,12.6[3.7]岁;20 名女孩[45%])入组。与对照组相比,MIS-C 组更频繁地出现神经系统检查异常(61 名儿童中有 15 名[25%] vs 43 名儿童中有 3 名[7%];优势比,4.7;95%CI,1.3-16.7)。尽管两组在大多数认知测量上表现相似,但 MIS-C 组在国家卫生研究院认知工具包列表排序工作记忆测试中的得分较低,这是一种执行功能的测量(平均[SD]分数,96.1[14.3] vs 103.1[10.5])。与对照组相比,患儿父母报告的心理结局更差,尤其是抑郁症状评分较高(平均[SD]分数,52.6[13.1] vs 47.8[9.4])和躯体化症状评分较高(平均[SD]分数,55.5[15.5] vs 47.0[7.6])。自我报告(平均[SD]分数,79.6[13.1] vs 85.5[12.3])和家长报告(平均[SD]分数,80.3[15.5] vs 88.6[13.0])的生活质量评分也低于对照组。

结论和相关性

在这项队列研究中,与同期的兄弟姐妹或社区对照者相比,MIS-C 患儿的神经系统检查异常更多,工作记忆评分更差,躯体化和抑郁症状更多,出院后 6 至 12 个月生活质量更低。尽管这些发现需要在更大的研究中得到证实,但可能需要加强监测,以便早期发现和治疗神经和心理症状。

相似文献

1
Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children.儿童多系统炎症综合征相关的神经和心理后遗症。
JAMA Netw Open. 2023 Jul 3;6(7):e2324369. doi: 10.1001/jamanetworkopen.2023.24369.
2
Levels of Complement Components in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome.急性 COVID-19 或多系统炎症综合征患儿补体成分水平。
JAMA Netw Open. 2023 Mar 1;6(3):e231713. doi: 10.1001/jamanetworkopen.2023.1713.
3
Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children.中东地区儿童多系统炎症综合征患者的遗传和临床特征。
JAMA Netw Open. 2022 May 2;5(5):e2214985. doi: 10.1001/jamanetworkopen.2022.14985.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study.儿童多系统炎症综合征的短期和中期临床结局:一项前瞻性观察性队列研究。
Ital J Pediatr. 2024 Jan 4;50(1):1. doi: 10.1186/s13052-023-01569-7.
6
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.美国 SARS-CoV-2 感染人群中儿童多系统炎症综合征的发病率。
JAMA Netw Open. 2021 Jun 1;4(6):e2116420. doi: 10.1001/jamanetworkopen.2021.16420.
7
Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C.急性 SARS-CoV-2 或 MIS-C 住院患儿神经系统表现的患病率及危险因素。
Pediatr Neurol. 2022 Mar;128:33-44. doi: 10.1016/j.pediatrneurol.2021.12.010. Epub 2021 Dec 28.
8
Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19.儿童多系统炎症综合征与 COVID-19 相比的并发症、药物不良反应、高成本和差异。
JAMA Netw Open. 2023 Jan 3;6(1):e2244975. doi: 10.1001/jamanetworkopen.2022.44975.
9
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.2021 年与 2020 年相比,美国儿童住院患者中 COVID-19 或儿童多系统炎症综合征严重神经系统受累分布的变化。
JAMA Neurol. 2023 Jan 1;80(1):91-98. doi: 10.1001/jamaneurol.2022.3881.
10
Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.美国国家 COVID 队列协作研究中儿童感染 SARS-CoV-2 的特征、结局和严重程度危险因素。
JAMA Netw Open. 2022 Feb 1;5(2):e2143151. doi: 10.1001/jamanetworkopen.2021.43151.

引用本文的文献

1
Two-year follow-up on multisystem inflammatory syndrome in children (MIS-c): findings from a tertiary paediatric hospital in Latvia.儿童多系统炎症综合征(MIS-c)的两年随访:拉脱维亚一家三级儿童医院的研究结果
Eur J Pediatr. 2025 Aug 9;184(9):542. doi: 10.1007/s00431-025-06253-y.
2
Neurologic and Psychological Outcomes 2 Years After Multisystem Inflammatory Syndrome in Children.儿童多系统炎症综合征2年后的神经和心理结局
JAMA Netw Open. 2025 Jun 2;8(6):e2512487. doi: 10.1001/jamanetworkopen.2025.12487.
3
Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children.

本文引用的文献

1
Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU.儿童重症监护病房收治的多系统炎症综合征后神经认知、心理社会和生活质量结局。
Pediatr Crit Care Med. 2023 Apr 1;24(4):289-300. doi: 10.1097/PCC.0000000000003180. Epub 2023 Jan 23.
2
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.2021 年与 2020 年相比,美国儿童住院患者中 COVID-19 或儿童多系统炎症综合征严重神经系统受累分布的变化。
JAMA Neurol. 2023 Jan 1;80(1):91-98. doi: 10.1001/jamaneurol.2022.3881.
3
儿童多系统炎症综合征重症监护入院后1年的多维结局
Crit Care Explor. 2025 Jan 22;7(1):e1213. doi: 10.1097/CCE.0000000000001213. eCollection 2025 Jan.
4
Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.儿童多系统炎症综合征研究的长期结局中的六个月结局
JAMA Pediatr. 2025 Mar 1;179(3):293-301. doi: 10.1001/jamapediatrics.2024.5466.
5
Consequences beyond acute SARS-CoV-2 infection in children.儿童急性 SARS-CoV-2 感染以外的后果。
Sci Transl Med. 2024 Nov 13;16(773):eado2099. doi: 10.1126/scitranslmed.ado2099.
6
Long-term health outcome and quality of life in children with multisystem inflammatory syndrome: findings from multidisciplinary follow-up at an Italian tertiary-care paediatric hospital.多系统炎症综合征患儿的长期健康结局和生活质量:来自意大利三级儿童保健医院多学科随访的结果。
Eur J Pediatr. 2024 Nov;183(11):4885-4895. doi: 10.1007/s00431-024-05706-0. Epub 2024 Sep 10.
7
Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors.多系统炎症综合征(MIS-C)儿科患者出现精神疾病后果的风险升高:神经炎症和心理社会应激源综述
Brain Behav Immun Health. 2024 Mar 18;38:100760. doi: 10.1016/j.bbih.2024.100760. eCollection 2024 Jul.
8
Long COVID's Impact on Patients, Workers, & Society: A review.长新冠对患者、劳动者和社会的影响:综述。
Medicine (Baltimore). 2024 Mar 22;103(12):e37502. doi: 10.1097/MD.0000000000037502.
9
Post-discharge outcomes of hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C.确诊为急性SARS-CoV-2感染或儿童多系统炎症综合征(MIS-C)的住院患儿出院后的结局
Front Pediatr. 2024 Feb 12;12:1340385. doi: 10.3389/fped.2024.1340385. eCollection 2024.
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C.
急性 COVID-19 或 MIS-C 住院后儿童和青少年的健康损害。
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2022-057798.
4
Measuring Social Health Following Pediatric Critical Illness: A Scoping Review and Conceptual Framework.测量儿科危重症后的社会健康:一项范围综述和概念框架
J Intensive Care Med. 2023 Jan;38(1):32-41. doi: 10.1177/08850666221102815. Epub 2022 May 22.
5
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.美国风湿病学会儿童 COVID-19 相关 SARS-CoV-2 与儿童多系统炎症综合征及过度炎症的临床指导:第 3 版
Arthritis Rheumatol. 2022 Apr;74(4):e1-e20. doi: 10.1002/art.42062. Epub 2022 Feb 3.
6
Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C.急性 SARS-CoV-2 或 MIS-C 住院患儿神经系统表现的患病率及危险因素。
Pediatr Neurol. 2022 Mar;128:33-44. doi: 10.1016/j.pediatrneurol.2021.12.010. Epub 2021 Dec 28.
7
6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study.英国一家三级儿科医院儿科炎症性多系统综合征(PIMS-TS)患者的 6 个月多学科随访和结局:一项回顾性队列研究。
Lancet Child Adolesc Health. 2021 Jul;5(7):473-482. doi: 10.1016/S2352-4642(21)00138-3. Epub 2021 May 25.
8
Preliminary evidence on long COVID in children.儿童长期新冠的初步证据。
Acta Paediatr. 2021 Jul;110(7):2208-2211. doi: 10.1111/apa.15870. Epub 2021 Apr 18.
9
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.
10
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.美国因新冠病毒病或多系统炎症综合征住院的儿童和青少年的神经系统受累情况
JAMA Neurol. 2021 May 1;78(5):536-547. doi: 10.1001/jamaneurol.2021.0504.